Stem Cell Pioneer Joins Forces with Stem Cell Fraudster
By Ahn Mi-Young and Dennis Normile,
Science Insider
| 02. 10. 2015
Untitled Document
The scientist who once fraudulently claimed to have created embryonic stem cells matched to human patients and the one who really did it plan to conduct joint research, a Korean newspaper reported this morning. A Chinese regenerative medicine company will provide financial support, according to the account.
The two scientists would seem an odd match. In 2006, Woo Suk Hwang had to retract two papers published in Science in which his team claimed it had used the technique employed in cloning Dolly the sheep to create human embryonic stem cells matched to specific people who had various diseases. After investigators determined all the claims were bogus, Hwang was fired from Seoul National University and later convicted of embezzling research funds and bioethics violations. He escaped jail time with a suspended sentence. Since his downfall, Hwang has quietly continued his cloning work on animals, particularly pet dogs, at Seoul-based Sooam Biotech Research Foundation, a private institute friends established specifically for him.
Despite his claims being deemed fraudulent by a Seoul National University panel, Hwang was awarded an...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...